We are live on
!
Find out more
VP
Vitruvian Partners Portfolio holdings
AUM
$112M
1-Year Est. Return
2.02%
This Fund
S&P 500
This Quarter
Est. Return
+13.46%
1 Year Est. Return
+2.02%
3 Year Est. Return
+35.84%
5 Year Est. Return
+18.92%
10 Year Est. Return
–
AUM
$116M
AUM Growth
-$141M
(-55%)
Cap. Flow
-$145M
Cap. Flow
% of AUM
-125.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
1
Increased
–
Reduced
2
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
RxSight
RXST
|
+$6.51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global E Online
GLBE
|
+$138M |
| 2 |
CarGurus
CARG
|
+$10.8M |
| 3 |
Xometry
XMTR
|
+$2.64M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 38.14% |
| 2 | Consumer Discretionary | 29.75% |
| 3 | Healthcare | 22.33% |
| 4 | Industrials | 9.78% |
Similar funds
RTM
JE
GW
SPWM
OCA
APFP
FCU
DM
Vitruvian Partners's Q4 2024 Portfolio in Review
As of Q4 2024, Vitruvian Partners held 7 positions worth $116M, down 55% from $257M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Vitruvian Partners withdrew a net $145M in Q4 2024, closing 1 position and reducing 2 holdings. Its most notable exit was Global E Online, an estimated $138M position sold in full.
By sector, the portfolio is most concentrated in Technology at 38% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Vitruvian Partners opened a new position in RxSight worth $4.96M.
- Vitruvian Partners's largest Q4 2024 buy was RxSight: 144,300 shares worth $4.96M.
- Vitruvian Partners's biggest Q4 2024 reduction was CarGurus, cutting an estimated $10.8M.
- Vitruvian Partners fully exited Global E Online in Q4 2024, selling an estimated $138M.
- Vitruvian Partners's ten largest holdings make up 100% of its $116M portfolio in Q4 2024.
- Vitruvian Partners opened 1 new position and closed 1 in Q4 2024.
- Vitruvian Partners's portfolio value fell 55% quarter-over-quarter to $116M.
Based on Vitruvian Partners's 13F filing for Q4 2024, filed 11 Feb 2025.